TY  - JOUR
AU  - Lopez-Millan, Belen
AU  - Costales, Paula
AU  - Gutiérrez-Agüera, Francisco
AU  - Díaz de la Guardia, Rafael
AU  - Roca-Ho, Heleia
AU  - Vinyoles, Meritxell
AU  - Rubio-Gayarre, Alba
AU  - Safi, Rémi
AU  - Castaño, Julio
AU  - Romecín, Paola Alejandra
AU  - Ramírez-Orellana, Manuel
AU  - Anguita, Eduardo
AU  - Jeremias, Irmela
AU  - Zamora, Lurdes
AU  - Rodríguez-Manzaneque, Juan Carlos
AU  - Bueno, Clara
AU  - Morís, Francisco
AU  - Menendez, Pablo
PY  - 2022
DO  - 10.3390/cancers14061593
SN  - 2072-6694
UR  - http://hdl.handle.net/10668/20880
T2  - Cancers
AB  - Acute myeloid leukemia (AML) is the most common acute leukemia in adults. Patients with AML harboring a constitutively active internal tandem duplication mutation (ITDMUT) in the FMS-like kinase tyrosine kinase (FLT3) receptor generally have a poor...
LA  - en
KW  - AML
KW  - AML preclinical model
KW  - EC-70124 multi-kinase inhibitor
KW  - FLT3 inhibitor
KW  - FLT3-ITD mutation
TI  - The Multi-Kinase Inhibitor EC-70124 Is a Promising Candidate for the Treatment of FLT3-ITD-Positive Acute Myeloid Leukemia.
TY  - research article
VL  - 14
ER  -